Anaconda Biomed, SL, announced the publication of results of the ANAIS study, which evaluated the safety and performance of the c ...

April 15, 2025—enVVeno Medical Corporation recently announced the presentation of findings from a subanalysis of the 1-year data from the prospe ...

Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced that the company’s dual-layer micromesh carotid st ...

Imperative Care, Inc. announced it will fund an investigator-initiated, multicenter, randomized controlled clinical trial compari ...

Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, annou ...

Anaconda Biomed, SL, a developer of next-generation neurothrombectomy devices, recently announced the enrollment and ...

In an article published online in Journal of Vascular Surgery evaluating radiation dose exposure for vascular surgery ...

Surmodics, Inc. announced the full commercial release of the Pounce XL thrombectomy system. Pounce XL is intended for the ...

Boston Scientific announced via social media that it has closed the acquisition of Bolt Medical, which recently gained FDA ...

Brainomix announced the FDA clearance of a feature that enables physicians to assess ischemic core volume from universally ...

Cagent Vascular, Inc. announced that the first patient was enrolled in the Serranator OCT study. The study will use intravascular ...

Cagent Vascular, Inc., the developer of serration technology for vessel dilation in endovascular interventions, announced its stra ...